Stage IVB Squamous Cell Carcinoma of the Oropharynx Completed Phase 2 Trials for Saracatinib (DB11805)

IndicationStatusPhase
DBCOND0029855 (Stage IVB Squamous Cell Carcinoma of the Oropharynx)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00513435Saracatinib in Treating Patients With Recurrent or Metastatic Head and Neck CancerTreatment